Extracellular matrix degradation and the role of hepatic stellate cells

Seminars in Liver Disease

Volumn 21, Issue 3, 2001, Pages 373-384

  Benyon, R C ^a   Arthur, M J P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Liver fibrosis; Matrix degradation; Matrix metalloproteinases; Tissue inhibitor of metalloproteinases

Indexed keywords

COLLAGENASE 3; GELATINASE; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; STELLATE CELL;

CELL CULTURE TECHNIQUES; COLLAGENASES; DOWN-REGULATION; EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASES; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034814405     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17552     Document Type: Review

References (84)

1. Matrix metalloproteinases
2. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
3. Evidence for the involvement of type II domains in collagen binding by 72kDa type IV procollagenase
4. Matrix metalloproteinase-2 is an interstitial collagenase-inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments
5. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
6. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
7. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells
8. Cloning and sequencing of mouse collagenase cDNA - Divergence of mouse and rat collagenases from the other mammalian collagenases
9. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
10. Biochemical characterization of human collagenase-3
11. Different collagenase gene products have different roles in degradation of type I collagen
12. Native cross-links in collagen fibrils induce resistance to human synovial collagenase
13. Membrane-type matrix metalloproteinases
14. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation
15. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G
16. The plasminogen activator system: Biology and regulation
17. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
18. Mechanisms for pro matrix metalloproteinase activation
19. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2
20. A matrix metalloproteinase expressed on the surface of invasive turnout cells
21. Mechanism of cell surface activation of 72-kDa type IV collagenase - Isolation of the activated form of the membrane metalloprotease
22. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
23. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72kDa progelatinase by fibroblast membranes
24. MT1-MMP initiates activation of pro-MMP-2 and integrin alpha beta 3 promotes maturation of MMP-2 in breast carcinoma cells
25. Induction of matrix metalloproteinase activation cascades based on membrane type I matrix metalloproteinase
26. Cellular mechanisms for human procollagenase-3 (MMP-13) activationevidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate activate enzyme
27. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors
28. Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts
29. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs
30. All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts
31. Increased 9, 13-di-cis-retinoic acid in rat hepatic fibrosis: Implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo
32. Independent regulation of collagenase, 72kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta
33. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kD type IV collagenase
34. TGF-beta plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2
35. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression
36. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction
37. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells
38. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
39. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
40. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation-regulation by TIMP-2 and TIMP-3
41. Tissue inhibitors of matrix metalloproteinases
42. Replacement of conserved cysteines in human tissue inhibitor of metalloproteinases-1
43. Interaction of 92-kDa type-IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
44. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase
45. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
46. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
47. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines
48. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes
49. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells - A possible new growth factor in serum
50. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
51. TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin
52. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
53. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism
54. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases
55. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts
56. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
57. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro
58. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues
59. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) is expressed in early primary culture
60. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes
61. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
62. The plasminogen-activating system in hepatic stellate cells
63. Expression of tissue inhibitor of metalloproteinases-1 and -2 is increased in fibrotic human liver
64. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen
65. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation
66. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells
67. The discoidin domain receptor 2 (DDR2) is induced during stellate cell activation, mediates cell growth and matrix metalloproteinase 2 expression, and is regulated by extracellular matrix
68. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol
69. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver
70. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat
71. Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs
72. Extracellular matrix remodeling at the early stages of liver regeneration in the rat
73. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration
74. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis
75. Improvements in liver histology and cirrhosis with extended lamivudine therapy
76. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
77. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers
78. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis
79. Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease
80. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model
81. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
82. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis
83. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride
84. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model